US6989551014
US6989551014
Parabilis Medicines, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 152.079.000 | 126.125.000 | 20.6% | |
| Operating Income | -152.079.000 | -126.125.000 | 20.6% |
| Pretax Income | -145.889.000 | -117.914.000 | 23.7% |
| Net Income Common Stockholders | -186.933.000 | -161.481.000 | 15.8% |
| -- | -- | -- | |
| -- | -- | -- |